Cancel

Addressing Key Questions About BCMA-Targeted Therapy for Relapsed/Refractory Multiple Myeloma

ACTIVITY DESCRIPTION Though treatment advances have improved outcomes for most patients, MM remains an incurable disease characterized by continuous relapse. However, the treatment landscape for relapsed/refractory MM (RRMM) has expanded in recent years, and patients who relapse and/or become refractory to initial therapies are benefiting from the increasing availability of a diverse range of novel agents, including B-cell maturation antigen (BCMA)"targeted immunotherapies. These agents ...
Multiple Myeloma Research Foundation, RedMedEd, and Purdue University College of Pharmacy

“THEY TOO SHALL PASS: A JOURNEY THROUGH CARING FOR ADULT TRANSGENDER PATIENTS”

CLASS OVERVIEW This CE will allow providers to gain a solid foundation regarding transgender healthcare and the skills necessary to provide healthcare for transgender patients in a safe, supportive and welcoming environment EDUCATIONAL/LEARNING OBJECTIVES: 1. Recognize and apply gender confirming and gender-nonconforming terminology to current practice 2. Review epidemiology of the LGBTQIA+ population 3. Design a welcoming, safe, and supportive environment for patients within the LGBTQI...
Western University of Health Sciences, College of Pharmacy

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map